Prostatectomy or radiotherapy for localized prostate cancer with a Gleason score of 8 or higher and a PSA level of 10 or lower is associated with a 5-year biochemical recurrence-free survival (bRFS) rate of 64%, according the results of a study conducted at the Cleveland Clinic Foundation in Ohio.
This “remarkably good” outcome is even better for men who also receive 6 months or less of androgen deprivation therapy, lead author Dr. Patrick A. Kupelian, now at the M. D. Anderson Cancer Center Orlando in Florida, and colleagues note. The 5-year bRFS rate for these patients is 78%.
תגובות רוצה להצטרף לדיון?
יש להתחבר כדי להגיב.
התחבראין תגובות עדיין. היה הראשון להגיב!